S&D Co (260970) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
25 Jun, 2026Executive summary
Specializes in functional food ingredients and health supplements, with diversification into natural materials for cosmetics and household goods.
Achieved certifications such as ISO22000, ISO14001, and HACCP, and completed a dedicated health food material plant.
No subsidiaries or affiliates; listed on KOSDAQ since 2021.
Financial highlights
Q1 2025 revenue: KRW 35.7 billion, down from KRW 116.1 billion in FY2024.
Q1 2025 net income: KRW 4.39 billion, compared to KRW 17.03 billion in FY2024.
Q1 2025 operating income: KRW 5.38 billion.
Basic EPS for Q1 2025: KRW 1,518 (Q1 2024: KRW 698).
Gross margin for Q1 2025: 21.4%.
Outlook and guidance
Expanding into new business areas for future growth, but no immediate plans for new business launches.
Ongoing investment in production capacity, with a new facility under construction expected to enhance efficiency.
Latest events from S&D Co
- H1 2024 saw lower sales and profit, but the company remains financially robust and innovative.260970
Q2 202425 Jun 2026 - 2024 Q3 revenue reached ₩81.5B, with net income of ₩11.2B and EPS of ₩3,334.260970
Q3 202425 Jun 2026 - H1 2025 revenue reached KRW 73.8B, with net income of KRW 9.3B and ongoing facility expansion.260970
Q2 202525 Jun 2026 - 2025 Q3 revenue was KRW 112.87B, net income KRW 14.26B, with stable dividends and strong cash.260970
Q3 202525 Jun 2026 - Q1 2026 revenue and profit surged, supported by strong core sales and a major share buyback.260970
Q1 202622 Jun 2026